TL
GSK icon

TrueWealth LLC’s GSK GSK Stock Holding History

TrueWealth LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$49K Hold
960
– – 0.02% 277
2020
Q1 		$45K Hold
960
– – 0.02% 266
2019
Q4 		$56K Hold
960
– – 0.02% 264
2019
Q3 		$51K Hold
960
– – 0.02% 260
2019
Q2 		$48K Sell
960
-50
-5% -$2.51K 0.02% 268
2019
Q1 		$53K Hold
1,010
– – 0.02% 258
2018
Q4 		$48K Hold
1,010
– – 0.02% 259
2018
Q3 		$51K Buy
1,010
+160
+19% +$8.13K 0.02% 265
2018
Q2 		$43K Sell
850
-45
-5% -$2.27K 0.02% 281
2018
Q1 		$44K Buy
895
+45
+5% +$2.1K 0.02% 270
2017
Q4 		$38K Buy
+850
New +$39.3K 0.02% 312

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TrueWealth LLC's GSK Position: Q2 2020 in Review

TrueWealth LLC held its GSK (GSK) position steady in Q2 2020 at 960 shares worth $49K. The position accounts for 0.02% of the portfolio, ranked #277.

TrueWealth LLC first reported a position in GSK in Q4 2017 and has held it in 11 quarters since. The position peaked at $56K in Q4 2019. 841 funds tracked by Wall St. Rank hold GSK as of Q2 2020.

  • TrueWealth LLC held 960 shares of GSK worth $49K as of Q2 2020.
  • TrueWealth LLC left its GSK share count unchanged in Q2 2020.
  • GSK made up 0.02% of TrueWealth LLC's portfolio in Q2 2020, its #277 holding.
  • TrueWealth LLC first reported a position in GSK in Q4 2017 and has held it in 11 quarters since.
  • TrueWealth LLC's GSK position peaked at $56K in Q4 2019.
  • 841 funds tracked by Wall St. Rank held GSK as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.